Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.

× No keyword cloud information.

24 in total

1. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro.

Authors: H Dorai; S Vukicevic; T K Sampath
Journal: J Cell Physiol Date: 2000-07 Impact factor: 6.384

2. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.

Authors: K N Cowan; P L Jones; M Rabinovitch
Journal: J Clin Invest Date: 2000-01 Impact factor: 14.808

3. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

Authors: Z Deng; J H Morse; S L Slager; N Cuervo; K J Moore; G Venetos; S Kalachikov; E Cayanis; S G Fischer; R J Barst; S E Hodge; J A Knowles
Journal: Am J Hum Genet Date: 2000-07-20 Impact factor: 11.025

4. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors: K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal: Nat Genet Date: 2000-09 Impact factor: 38.330

5. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Authors: R C Trembath; J R Thomson; R D Machado; N V Morgan; C Atkinson; I Winship; G Simonneau; N Galie; J E Loyd; M Humbert; W C Nichols; N W Morrell; J Berg; A Manes; J McGaughran; M Pauciulo; L Wheeler
Journal: N Engl J Med Date: 2001-08-02 Impact factor: 91.245

6. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.

Authors: J H Newman; L Wheeler; K B Lane; E Loyd; R Gaddipati; J A Phillips; J E Loyd
Journal: N Engl J Med Date: 2001-08-02 Impact factor: 91.245

7. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.

Authors: N W Morrell; X Yang; P D Upton; K B Jourdan; N Morgan; K K Sheares; R C Trembath
Journal: Circulation Date: 2001-08-14 Impact factor: 29.690

8. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.

Authors: S Eddahibi; N Hanoun; L Lanfumey; K P Lesch; B Raffestin; M Hamon; S Adnot
Journal: J Clin Invest Date: 2000-06 Impact factor: 14.808

9. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.

Authors: S Eddahibi; V Fabre; C Boni; M P Martres; B Raffestin; M Hamon; S Adnot
Journal: Circ Res Date: 1999-02-19 Impact factor: 17.367

10. Mild hypoxia causes severe pulmonary hypertension in fawn-hooded but not in Tester Moriyama rats.

Authors: T Nagaoka; M Muramatsu; K Sato; I McMurtry; M Oka; Y Fukuchi
Journal: Respir Physiol Date: 2001-08

8 in total

Review 1. Idiopathic pulmonary arterial hypertension.

Authors: Amy L Firth; Jess Mandel; Jason X-J Yuan
Journal: Dis Model Mech Date: 2010 May-Jun Impact factor: 5.758

2. Functional constituents of a local serotonergic system, intrinsic to the human coronary artery smooth muscle cells.

Authors: Kannan Baskar; Swastika Sur; Vithyalakshmi Selvaraj; Devendra K Agrawal
Journal: Mol Biol Rep Date: 2015-04-11 Impact factor: 2.316

3. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.

Authors: Yinglin Liu; Barry L Fanburg
Journal: Am J Respir Cell Mol Biol Date: 2005-09-29 Impact factor: 6.914

4. Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.

Authors: Amy L Firth; Weijuan Yao; Carmelle V Remillard; Aiko Ogawa; Jason X-J Yuan
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-02-05 Impact factor: 5.464

Review 5. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors: Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal: Neuropharmacology Date: 2008-09-11 Impact factor: 5.250

Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.